Hint mode is switched on Switch off
For swift navigation between sections

Interpace Biosciences
LEI 5493006LRJROHHZJM864

PDF download

Choose all Reset all
Download Cancel
Organization name
Interpace Biosciences Inc (formerly Interpace Diagnostics Group Inc)
Country name
USA
Country of registration
USA
Industry
Medical Devices
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Interpace Biosciences Inc (formerly Interpace Diagnostics Group Inc) operates as a commercial and bioinformatics company. The Company provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services. Interpace Biosciences develops and commercializes molecular diagnostic tests that deliver cutting-edge genetic and mutational analysis.

Awards

News

20/01/2026 Interpace Biosciences: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
03/12/2025 Interpace Biosciences: Other Events, Financial Statements And Exhibits
08/05/2025 Interpace Biosciences: Results Of Operations And Financial Condition, Financial Statements And Exhibits
25/04/2025 Interpace Biosciences: Cost, Other Events, Financial Statements And Exh
28/02/2025 Interpace Biosciences: Nonreliance On Previously Issued Financial Statements Or A Related Audit Report Or Completed Interim Review
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493006LRJROHHZJM864
  • SIC
    3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001054102
Registration is required to get access.